SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-061367
Filing Date
2019-11-08
Accepted
2019-11-08 08:02:08
Documents
6
Period of Report
2019-11-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1922020d1_8k.htm 8-K 18835
2 EXHIBIT 99.1 tm1922020d1_ex99-1.htm EX-99.1 5181
3 EXHIBIT 99.2 tm1922020d1_ex99-2.htm EX-99.2 4823
4 GRAPHIC ex99x1_001.jpg GRAPHIC 190269
5 GRAPHIC ex99x2_001.jpg GRAPHIC 428820
6 GRAPHIC image_001.jpg GRAPHIC 5687
  Complete submission text file 0001104659-19-061367.txt   890973
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 191202144
SIC: 2834 Pharmaceutical Preparations